Research Correspondence

DOI: 10.4244/EIJ-D-24-00158

Temporal trends in characteristics of patients undergoing transcatheter tricuspid edge-to-edge repair for tricuspid regurgitation

Karl-Patrik Kresoja1,2, MD; Lukas Stolz3, MD; Anne Schöber1,2, MD; KarlPhilipp Rommel2, MD; Sebastian Rosch1,2, MD; Florian Schlotter2, MD; Muhammed Gerçek4, MD; Christoph Pauschinger5,6, MD; Wolfgang Rottbauer7, MD; Mohammad Kassar8, MD; Bjoern Goebel9, MD; Paolo Denti10, MD; Tienush Rassaf11, MD; Manuel Barreiro-Perez12, MD; Peter Boekstegers13, MD; Monika Zdanyte14, MD; Marianna Adamo15, MD; Flavien Vincent16, MD, PhD; Philipp Schlegel17, MD; Ralph-Stephan von Bardeleben1, MD; Mirjam G. Wild18, MD; Stefan Toggweiler19, MD; Mathias H. Konstandin17, MD; Eric Van Belle16, MD, PhD; Marco Metra15, MD; Tobias Geisler14, MD; Rodrigo Estévez-Loureiro12, MD; Peter Luedike11, MD; Francesco Maisano10, MD; Philipp Lauten9, MD; Fabien Praz8, MD; Mirjam Kessler7, MD; Andreas Ruck20, MD; Daniel Kalbacher5,6, MD; Volker Rudolph4, MD; Christos Iliadis21, MD; Holger Thiele3, MD; Jörg Hausleiter3,22, MD; Philipp Lurz1, MD, PhD; on behalf of the EuroTR investigators

In the last decade, the management of tricuspid regurgitation (TR) has significantly changed owing to the emergence of novel interventional treatment approaches that have allowed safe and effective treatment of TR. While retrospective studies suggested a survival benefit of interventional TR treatment as compared to patients treated conservatively12, the first randomised clinical trial that compared tricuspid transcatheter edge-to-edge repair (T-TEER) to optimal medical treatment, the TRILUMINATE Pivotal Trial, showed no differences at 1 year with regards to mortality or heart failure hospitalisation, albeit meeting its primary endpoint3. A possible explanation for this discrepancy might be attributable to a change in the characteristics of patients who are referred for T-TEER therapy nowadays, as compared to initial treatment experiences. Therefore, the aim of this study was to evaluate changes in the characteristics of patients referred for T-TEER and investigate their influence on outcomes.

Patients from the European Registry of Transcatheter Repair for Tricuspid Regurgitation (EuroTR) who underwent interventional therapy for symptomatic TR from 2016 until 2022 at 12 European study sites (Germany, Italy, Switzerland, Spain, France, and Sweden) were...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 22
Nov 18, 2024
Volume 20 Number 22
View full issue


Key metrics

Suggested by Cory
Trending articles
57.8

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
39.45

Clinical research

10.4244/EIJ-D-23-00725 Nov 19, 2023
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
39.45

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al
free
36.35

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
35.15

State-of-the-Art

10.4244/EIJ-D-23-00895 Apr 1, 2024
Percutaneous interventions for pulmonary embolism
Finocchiaro S et al
free
28.5

CLINICAL RESEARCH

10.4244/EIJV11I1A6 May 19, 2015
European expert consensus on rotational atherectomy
Barbato E et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved